Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,527 Hepatitis
clinical trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Institute for Liver Health
mi
from
Tucson, AZ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Health Care
mi
from
Worcester, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center
mi
from
Wyoming, MI
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
The Institute for Liver Health - Chandler
mi
from
Chandler, AZ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolinas Medical Center - Transplant Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Digestive Disease Consultants - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Homestead, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Identification to Elimination in HCV-Infected Individuals
Status: Enrolling, Phase
Updated: 4/25/2018
TruCare Internal Medicine and Infectious Diseases
mi
from
DuBois, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The HOPE Study: Characterizing Patients With Hepatitis B and C
Status: Enrolling, Phase
Updated: 12/31/1969
Institute of Human Virology at the University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Spring Gastroenterology
mi
from
Humble, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
North Alabama GI Research Center
mi
from
Madison, AL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
The Gastroenterology Group, P.C.
mi
from
Reston, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Richland, WA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Beaumont, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research of South Florida - Coral Gables
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
IMIC Research
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Bioclinica Research Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
California Liver Research Institute
mi
from
Pasadena, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southern California Liver Centers - San Clemente
mi
from
San Clemente, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Research and Education-Tuan Nguyen MD
mi
from
San Diego, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
The Crofoot Research Center, INC (DBA: Gordon E. Crofoot MD PA)
mi
from
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
California Liver Research Institute
mi
from
Pasadena, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
UNC Liver Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
Washington U CRS (2101)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Digestive Health Research
mi
from
Hermitage, TN
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase II
Updated: 12/31/1969
National Research Institute
mi
from
Panorama City, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Institute for Liver Health
mi
from
Tucson, AZ
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Garden City
mi
from
Garden City, KS
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling, Phase I, II
Updated: 8/7/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling, Phase I, II
Updated: 8/7/2014
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatitis C Clinical Trial
3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
Status: Enrolling
Updated: 5/31/2013
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Hepatitis C Clinical Trial
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling, Phase
Updated: 12/31/1969
Liver Clinic, Toronto Western Hospital, UHN
mi
from
Toronto,
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and a Pharmacokinetic Enhancer When Administered in Combination in Healthy Subjects
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Chronic Hepatitis C Virus Infection Clinical Trial
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Status: Enrolling, Phase II
Updated: 4/14/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling, Phase
Updated: 12/31/1969
UNC Pediatrics/NC Children's Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Gastroenterology Care for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Englewood, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Greenville, SC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
Houma Digestive Health Specialists
mi
from
Houma, LA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
San Jose Gastroenterology/Silicon Valley Research Institute
mi
from
San Jose, CA
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
AIG Research
mi
from
Hermitage, TN
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Cliniques Universitaires Saint-Luc
mi
from
Brussels,
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Nationwide Children's Hospital- The Ohio State University (OSU)
mi
from
Columbus, OH
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Pharmacokinetics of GS-0976 or Fenofibrate in Adults With Normal and Impaired Hepatic Function
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hepatitis C Virus (HCV) Clinical Trial
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens Hospital Colorado /ID# 157996
mi
from
Aurora, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Stand-Up MRI of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
SimonMed
mi
from
San Francisco, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Health Jacksonville-Gastroenterology Emerson
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Weill Cornell Medicine, Hepatology
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
Status: Enrolling, Phase IV
Updated: 12/31/1969
Cambridge Health Alliance Outpatient Addiction Services
mi
from
Somerville, MA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
The State University of New York, University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Scott & White All Saints Medical Center - Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Pinnacle Clinical Research
mi
from
Live Oak, TX
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
IMIC Research
mi
from
Miami, FL
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern California Permanente Medical Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Veteran's Administration Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Hepatitis B Clinical Trial
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
NYU Hepatology Associates
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Rocky Mountain Clinical Research, LLC - Littleton
mi
from
Littleton, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Wake Research Associates, LLC - Raleigh
mi
from
Raleigh, NC
Click here to add this to my saved trials
1 … 7 8 9 10 11 12 13 14 15